Ares Financial Consulting »

Lenz Therapeutics shares owned by Ares Financial Consulting

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Ares Financial Consulting from 13F filings

Historical chart of Ares Financial Consulting investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Ares Financial Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Ares Financial Consulting

Quarter filed Position value Share count Share price at filing
2026-03-31 $177 19 9.37

More positions owned by Ares Financial Consulting

Vanguard Total Stock Market Etf Etf (VTI)
Wisdomtree Floating Rate Treasury Fund Etf (USFR)
Dimensional U.s. Targeted Value Etf Etf (DFAT)
Dimensional Inflation-protected Securities Etf Etf (DFIP)
Dimensional International Core Equity Market Etf Etf (DFAI)
Nvidia Corporation Stock (NVDA)
Avantis U.s. Equity Etf Etf (AVUS)
Ishares 0-5 Year Tips Bond Etf Etf (STIP)
Pimco 15 Year Us Tips Index Exchange-traded Fund Etf (LTPZ)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Saba Closed End Funds Etf Etf (CEFS)
Vanguard Total International Stock Etf Etf (VXUS)
Apple Stock (AAPL)
Dimensional International Core Equity 2 Etf Etf (DFIC)

View all positions for Ares Financial Consulting

Top funds holding Lenz Therapeutics

RA Capital Management
FMR
Falcon Edge Capital
Versant Venture Management
BlackRock
UBS Group
Vanguard Group
Franklin Resources
72 Investment Holdings
Tang Capital Management
Intrinsic Edge Capital Management
Millennium Management
State Street Corporation
CAM Group Holding A/S
Squarepoint Ops

View all funds holding Lenz Therapeutics